Market revenue in 2023 | USD 60.8 million |
Market revenue in 2030 | USD 153.5 million |
Growth rate | 14.2% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Other Ablation Technologies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.7% in 2023. Horizon Databook has segmented the Brazil tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is a major economy in the region, which is expected to contribute to the growth of the tumor ablation market during the forecast period. It has the sixth-largest GDP in the world. According to WHO, among the Latin American countries,
Brazil has the best healthcare system with cost-effective treatment options. Brazil has 43 Joint Commission International (JCI) accreditations for hospitals and institutions. According to the International Medical Travel Journal, private healthcare spending in Brazil is about 60% higher than in most Latin American countries.
These factors have helped Brazil increase its share in the tumor ablation market. Growth can also be attributed to Sistema Unico de Saude (SUS), the public health system that provides health insurance to all citizens in Brazil.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into Brazil tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account